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As of December 1986, we have identified 23 symptomatic children with human immunodefi-
ciency virus (HIV) infection in New Haven. Twelve developed AIDS as manifested by
lymphocytic interstitial pneumonitis, Pneumocystis carinii pneumonia (PCP), and/or dissemi-
nated mycobacterial infections; seven of them have died. The remainder have milder clinical
syndromes, which include failure tothrive, diffuse lymphadenopathy, and parotid swelling. When
compared to adults with AIDS, children often have hypergammaglobulinemia and normal
numbers ofT4 lymphocytes. Intravenous drug abuse by the mother or mother's consort is the risk
factor in 87 percent ofthese children. Two families have now been identified with more than one
symptomatic child, but in no family is there evidence of spread from symptomatic children to
uninfected siblings. A prospective study was begun to attempt to assess the risk of developing
symptomatic HIV infection when a child is born to a mother with antibodies to HIV.
INTRODUCTION
One percent of reported cases of AIDS in the United States occur in children less
than 13 years of age [1]. The number of childhood AIDS cases is likely to rise in the
future as the epidemic spreads and involves larger numbers of heterosexual women.
Children are important subjects foranalysisoftheetiologic, pathogenic, and epidemio-
logic factors involved in AIDS. Since they have been infected with and harbor fewer
dormant infectious agents than adults, they should help decipher one of the principal
unanswered questions-why only some individuals with human immunodeficiency
virus (HIV) infection become symptomatic; that is, certain co-factors, which are
important in the development ofAIDS, might be more readily discernible in children.
Furthermore, some children who are HIV-infected may remain healthy until their
childbearing years. These children could be a reservoir of HIV infection for future
generations.
The etiologic agent of AIDS, a retrovirus of the lentivirus group, was identified in
1983 and 1984 [2,3]. This identification permitted the development of the serologic
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tests needed to make a specific diagnosis of HIV infection and to define, in precise
terms, transmission ofthe disease. In August 1984, we began studies of HIV infection
ofNew Haven children andtheirfamilies, using Western immunoblotting, which is the
most specific technique available for measuring antibody to HIV [4]. The results of
these studies through December 1986 form the basis ofthis report.
The First Cases
The earliest recognized childhood case in New Haven was a boy born in 1979. His
mother's principal consort was an intravenous drug abuser. At 16 months of age, the
child was admitted to the hospital with fever, weight loss, and lymphadenopathy. He
had hypergammaglobulinemia; pulmonary infiltrates and hilar adenopathy were seen
on chest X-ray. Periodic episodes of respiratory decompensation and one episode of
pneumococcal sepsis occurred between three and five years of age, by which time he
developed clubbing. On three occasions, lung biopsies revealed histologic changes
consistent with lymphocytic interstitial pneumonitis (LIP) and were found to contain
Epstein-Barr virus (EBV) DNA [5]. When the patient first presented, pediatric AIDS
was not well-recognized and various other diagnoses were entertained, including
pulmonary hemosiderosis and the "X-linked lymphoproliferative syndrome" [6]. We
subsequently found that the child and his mother had HIV antibodies. This patient is
now seven years old and doing well. He is being treated with small doses ofsteroids.
Our second pediatric AIDS patient was born in 1982 to a prostitute who abused
heroin. At the time ofhospitalization at seven months ofagefor meningococcemia, the
baby was noted to have persistent fever, hepatosplenomegaly, and thrush. Lympho-
cytic interstitial pneumonitis was demonstrated by lung biopsy. Laboratory findings
included hypergammaglobulinemia and low numbers of T4 lymphocytes. At age 21
months, hedeveloped a B-cell lymphoma ofthe central nervous system associated with
EBV DNA [7]. At 31 months of age, he died of disseminated Mycobacterium
avium-intracellulare infection. HIV serology was positive in the child and the
mother.
The third patient, a girl born in 1982, was healthy until six months of age. She
developed Pneumocystis carinii pneumonia (PCP) and rapidly died of respiratory
failure. This fulminant course was mysterious since she had no identifiable underlying
congenital immune deficiency. Both parents were subsequently found to be HIV-
seropositive, and both developed AIDS and died. The father was a secretive intrave-
nous drug abuser.
Clinical Characteristics ofTwenty-Three Children with HIVInfection
Thus far we have identified 23 children with symptomatic HIV infection. Twelve of
the 23 children with HIV antibodies had severe disease and met the case definition of
pediatric AIDS; seven have died. Children with AIDS had well-recognized major
complications such as PCP (five patients), lymphocytic interstitial pneumonia (LIP)
(six patients), progressive encephalopathy (two patients), and/or disseminated myco-
bacterial infection, ofwhich the latter was always fatal (four patients) [8,9,10]. Oneof
the children with PCP also had received multiple blood transfusions and a bone
marrow transplant for leukemia. Therefore, in this case, it is impossible to be certain
whether PCP was related to the child's underlying disease and therapy or to the HIV
infection.
The remaining 11 children have milder illnesses, manifesting as failure to thrive,
developmental delay, persistent candidiasis, adenopathy, parotitis, or bacterial sepsis.
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As noted by others, many children with HIV infection are first seen because of an
episode of sepsis due to one of the common encapsulated bacterial pathogens, such as
pneumococcus or meningococcus. The problem of classifying the milder disease has
been emphasized, and there is at present no agreed-upon definition of "AIDS-related
complex" (ARC) in childhood. The presence ofantibody to HIV and the identification
of a known epidemiologic risk factor, such as parental drug abuse or a history ot
multiple blood transfusions, help in the differential diagnosis. Only a few children in
the New Haven group have had facies reminiscent of the dysmorphisms which have
been described by others [11].
Some children with lymphocytic interstitial pneumonitis and no other opportunistic
infection seem to do quite well. Episodes ofrespiratory failure have responded acutely
to aggressive respiratory support and large doses of corticosteroids. After clinical
recovery, most are maintained on very small every-other-day doses ofprednisone.
CLINICAL LABORATORY FINDINGS
Several laboratory findings are distinctive in children with HIV infection. One is
marked polyclonal hypergammaglobulinemia, a finding seen in ten of 12 children in
our original series, as well as by others [4,12,13]. Only two of our patients did not
manifest this abnormality; both were infants who died before the age ofsix months. It
is not known whether these immunoglobulins have antigen specificity; however, a
variety of autoantibodies have been observed in children with AIDS [8]. It is possible
that these antibodies are one manifestation of EB virus-mediated B-cell stimulation.
A second unusual feature of childhood AIDS is that children usually do not have
lymphopenia and often have normal numbers of T4 lymphocytes. In our earlier series,
only two of ten children had low numbers of T4 cells; the remainder had normal or,
occasionally, elevated numbers of T4 lymphocytes [4]. Thus, the hypothesis that the
opportunistic infections associated with AIDS are due solely to virus-induced cytolysis
ofT4 lymphocytes does not adequately explain the pathogenesis ofchildhood AIDS.
Children with HIV infection do have reversals ofthe ratioofT4 to T8 cells; however,
in most instances, the reversed ratio is due to a relative increase in the numbers of T8
cells. This increased number ofT8 cells may be due to concurrent viral infections with
agents such as Epstein-Barr virus (EBV) and cytomegalovirus, which are known to
cause an increase in the number ofcytotoxic and suppressor cells [14,151. Perhaps the
T8 cells exert an ameliorating effect on the course ofthe dsease, as has been suggested
by in vitro experiments [16].
The third unusual featureofchildhood AIDS is lymphocytic interstitial pneumonitis
(LIP). Most children with this disease have extremely high antibody titers to the
replicative antigens (capsid and early antigens) of EB virus, and their lung tissue
contains EBV DNA. On the otherhand, children with AIDS and PCPusually have low
or absent antibodies to the EBV replicative antigens and no EBV DNA in the lung [5].
Finally, mostchildren with AIDS and LIP have low antibody titers to the Epstein-Barr
nuclear antigen (EBNA) and often lack antibody to that component of EBNA
(designated EBNA 1) encoded by the BamHI K region of the genome [17]. Thus
elevated antibody to EBV capsid and early antigens and lack ofantibody to EBNA 1
can serve as an adjunct to the diagnosis of LIP.
SERODIAGNOSIS OF HIV INFECTION IN CHILDREN
We have used the Western blot technique to measure antibodies to HIV [4]. Every
serum was simultaneously tested against HTLV III B virus purified on sucrose
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gradients, HTLV III B-infected H9 cells, and uninfected H9 cells. H9 cells are a clone
of the HT T-cell leukemia line which support HIV replication [3]. Our purpose in
using this panel ofantigens is to distinguish HIV-specific reactions from those that are
due to anticellular reactivity. In most instances, the sera from children have also been
examined for antibodies using commercially available ELISA kits.
Several features of the serologic response to HIV in children merit comment. In
general, the reactivity of sera from children is weaker than that from infected adults,
particularly their parents. Children who are HIV-infected, as demonstrated by virus
isolation or by the presence of antibody to HIV detectable by Western blotting, are
sometimes seronegative by ELISA [4]. In some children, the presence ofantibodies by
Western blotting can only be shown after the use of bridging anti-immunoglobulins.
Children recognize fewer polypeptides on Western blots than do their parents [4].
Most of the mothers and fathers in our series recognized nearly all of the nine
polypeptide clusters which we see on immunoblots. Among our original group of 12
sera from 13 children, sera from six recognized four or fewer polypeptides. Three of
these six children reacted with only oneor twoproteins, polypeptides of62 KDa and 25
KDa. The responseofthe other six children was comparable to that seen in adults; sera
from this group reacted with seven, eight, or all nine polypeptide clusters. The weak
reactors were younger (mean age, 1.3 years) than those with an adult type ofserologic
response (mean age, 2.6 years).
In children less than six months of age, the presence of antibodies to HIV could
reflect transfer of maternal IgG anti-HIV antibodies across the placenta. Thus,
antibodies per se are not necessarily indicative of infection. At present there are two
ways to determine whether the young infant with HIV antibodies is actually infected.
The first is to detect virus-by isolation in culture, antigen detection, or by in situ
hybridization. The second is to show that the infant's antibody titers fail to wane,
increase with time, or that reactivities to specific proteins, initially absent in the
neonatal period, begin to appear later in infancy [18,19]. The measurement ofspecific
IgM antibodies, a technique which has been so useful in rubella and other congenital
infections, has not yet been found to be useful for HIV.
INTRAVENOUS DRUG ABUSE IS THE MAIN RISK FACTOR FOR
CHILDHOOD HIV INFECTION IN NEW HAVEN
The epidemiology ofAIDS in New Haven differs significantly from the epidemiol-
ogy of the disease in the U.S. at large (Table 1). These differences help explain why
childhood AIDS and HIV infection are so prevalent in New Haven. The epidemiology
ofAIDS in New Haven is characterized by a relatively large fraction of patients who
are intravenous drug abusers or heterosexual partners of those who use intravenous
drugs, whereas the majority of AIDS cases in the U.S. are male homosexuals.
Therefore, locally, there are relatively more reported cases in women and, accordingly,
in children.
Of pediatric cases reported from Yale-New Haven Hospital, intravenous drug use
by a parent was the risk factor in 20 of 23 symptomatic children (87 percent) (Table
2). In contrast, one child's father was a bisexual who had spent time in prison, and two
children apparently acquired the infection through blood transfusions. Of these latter
two, one was the leukemic child discussed previously, and the other was a child who
received an exchange transfusion while being treated for fulminant meningococce-
mia.
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TABLE 1
Comparison of Reported AIDS Cases in the City of New Haven and the Country as a Whole
(Cumulative through December 1986)
USA City ofNew Haven
Number ofCDC-defined cases 29,003 80
Risk Groups'
Homosexual/Bisexual male 66% 31%
Intravenous drug abuser (IVDA) 17% 43%
Homosexual male and IVDA 8% 4%
Heterosexual sex partner 4% 11%
Hemophilia 1% 0
Transfusion recipient 2% 3%
Children 1% 6%
Undetermined 2% 3%
Ethnic Group
White 60% 23%
Black 24% 61%
Hispanic 14% 14%
Other/Unknown 2% 2%
Gender
Male 92% 71%
Female 8% 29%
Cases/Million 92 634
'Percentages do not add up to 100 percent because ofrounding error.
The 20 children with symptomatic HIV infection which resulted from parental
intravenous drug abuse were members of 17 families. In ten of the 17 families, the
mother herself was known to use intravenous drugs; in seven families the mother
denied intravenous drug abuse but had as her principal sexual consort an intravenous
drug abuser. In these families the mother presumably became infected heterosexually
and transmitted the infection to her infant. This conclusion must be tempered by the
caveat that the histories from the mothers may not always be reliable.
Age
Our HIV-infected children developed symptoms between one month and six years of
age (Table 3). The median age at onset of symptoms was 18 months. Therefore, the
TABLE 2
Summary of Symptomatic Childhood HIV Infection Diagnosed at Yale-New
Haven Hospital, by Risk Factor, Through December 1986
Number ofChildren
Risk Factor with Symptoms Number with AIDS
Parental Drug Use 20 10
Father Bisexual 1 1
Transfusion 2 1
Total 23 12
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TABLE 3
Symptomatic HIV Infection in New Haven Children, by Age, Through December 1986
Age at Onset Number S AIDS Death
<12 months 7 30 3 2
12-24 months 8 35 5 3
25-36 months 3 13 1 0
>36 months 5 22 3 2
Total 23 100 12 7
incubation period for clinically expressed pediatric AIDS is 18-27 months, depending
on whether the infection is acquired at the time ofbirth or in utero.
HIVInfection in Families ofSymptomatic Children
In our original group of 14 children, sera were available from 12 of the 14 mothers.
All of the mothers' sera contained antibodies to HIV. One mother died of AIDS,
another of a drug overdose; the rest were not symptomatic. We could locate only five
fathers; one of them, who was not living in the same household as the child and his
mother, was HIV-seronegative. The other four fathers were seropositive, and one died
ofAIDS.
The situation in siblings was instructive in several respects. In our original study,
only oneofeight siblings ofindex cases wasseropositive [4]. This finding indicated that
HIV was not readily spread from infected parents or infected children to siblings, as
others have also found [4,20,21]. Furthermore, parent surrogates who cared for two
children during prolonged hospitalizations remained HIV-seronegative. Finally, we
have studied one family in whom all members are seronegative, even after the parents
dressed the open wounds of their infected child for two years prior to discovery of his
serologic status.
In the expanded group presented in this report, we now have two families in which
there is more than one infected symptomatic child: one family from our previous study
now has a third symptomatic child and another newly recognized family has two. Thus
three of 14 siblings are HIV-seropositive (Table 4). In the original family with two
symptomatic children, the infected older sibling was presumably infected in utero, at
birth, or in the neonatal period by the mother. After his younger brother presented to
us, he was evaluated and found to have thrush and diffuse adenopathy. Although the
two sibs have different fathers, both were intravenous drug users and the mother was
seropositive at the time the younger child was first examined. Among the seronegative
siblings of index cases was a fraternal twin and a younger sibling. These findings
indicate that an infected mother can give birth both to infected and uninfected
children.
Only prospective studies will define precisely the risk associated with being born to a
carrier mother, although, in preliminary studies to date, the risk of being born with
HIV infection to a mother who has previously given birth to a child with HIV infection
is estimated to range from 33-92 percent [22,23].
PREVENTION OF TRANSMISSION OF HIV INFECTION TO CHILDREN
Invirtually all instances, infected, butusually asymptomatic, mothers transmit HIV
infection to their children. Occasionally, HIV infection has been transmitted to
children through blood or blood products [24].
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TABLE 4
HIV Antibody in Siblings in Families with a Child with AIDS/ARC
Number ofSiblings' Number ofSiblings
Family Designation Tested for Antibodies Antibody-Positive
A 1 0
B 2 0
C 2 0
D 4 2
E 2 1
F 3 0
Total 14 3
'Excludes the index case
Interruption of transmission from mother to child requires a more detailed under-
standing of the pathogenesis of perinatal infection. There are several different means
whereby transmission may occur. Virus may pass from the maternal blood across the
placenta and infect the fetus in utero. Among the findings which would implicate in
uterotransmission areinfection ofthe placenta, isolation ofvirus from the infant in the
first days of life, and the presence of a distinct constellation of congenital malforma-
tions. The virus may be acquired during birth as the infant passes through the birth
canal. Ifthis is a significant modeoftransmission, Cesarean section might help prevent
infection. There are, however, cases of children with AIDS who have been born by
Cesarean section [25]. Finally, the infant may be infected in the postnatal period by
close personal contact, or breast feeding, as has been reported in a single case [26].
Since non-venereal personal contact does not appear to spread the infection to older
children, one would need to postulate, under the lattercircumstances, that the newborn
infant is more susceptible to infection by personal contact than the older child.
Although all three modes of transmission may occur, some evidence favors the
pathway ofintrauterine infection, i.e., the craniofacial abnormalities which have been
described, the occasional isolation ofvirus from placenta and fetus, and the rapid onset
ofdisease during the first months oflife in some infants [8]. Perhaps sampling of fetal
blood or other tissues for virus will help confirm the incidence of intrauterine
infection.
If public health policy is to be directed at the prevention of HIV infection of
children, we need to learn more about the risks associated with being born to a
seropositive mother. Our study of families, albeit small, permits some tentative
conclusions. Not all infected mothers give birth to infected children. We and others
have described twins, one of whom escaped infection [27]. Occasionally younger
siblings of children with AIDS remain uninfected [23]. Nonetheless, some families
appear to be at greater risk. Two mothers in our series have borne successive children
with symptomatic HIV infection.
The only way to assess the risk to infants of seropositive mothers is to carry out a
prospective study. Such a study was started in New Haven in December 1985 (Table
5). The idea was to identify infants who were seropositive at or around the timeofbirth
and then follow them. Twenty-two infants born to twenty mothers were identified in a
year. These infants' mothers were enrolled in a methadone program, were known
intravenous drug addicts who did not participate in a treatment program, or were
consorts of intravenous drug addicts (Table 5). The infants will be followed serologi-
cally and for the development ofsymptomatic HIV infection. Thus far, three of them
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TABLE 5
Prospective Study of 22 Infants Who Were Born HIV-Seropositive,
December 1985-December 1986
Maternal Risk Factor Number ofMothers'
Mother in Methadone program 8
Mother drug-addicted 6
Consort drug-addicted 4
Unknown 2
Total 20
'Each oftwo mothers gave birth to a pair ofseropositive twins.
appear to besymptomatic: onewhopresented with pneumococcal sepsis and shock, one
who presented with pneumococcal bacteremia and subsequently developed PCP, and
one who presented with Salmonella sepsis and was found to have diffuse cortical
atrophy. Several infants who were antibody-positive at birth have lost their antibody,
which was presumably ofmaternal origin, and remain well.
PUBLIC POLICY QUESTIONS
Questions are frequently asked about the potential infectivity ofchildren with AIDS
or pre-AIDS in school situations and at home. Our opinion that these children
represent no great hazard tocaregivers and classmates is based on the observation that
individuals who provide close care to infected infants and children, such as nursing
staff, grandmothers, foster mothers, and mother surrogates are not seropositive,
although there is onevery unusual case report to the contrary [28]. Furthermore, older
siblings and even twins in the same household, exposed both to infected parents and to
infected younger brothers and sisters, remain seronegative in our studies and in others.
When more than one seropositive sibling is found, it has been assumed that a carrier
mother has passed the infection to more than one child in utero or during the neonatal
period. For these reasons, we believe that infected children can be placed in their
natural homes, foster care, and in school with very little risk.
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